Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome. Gynecologic oncology

Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari, Laura Arenare, Domenica Lorusso, Graziana Ronzino, Rossella Lauria, Gennaro Cormio, Claudia Carella, Paolo Scollo, Viola Ghizzoni, Francesco Raspagliesi, Marilena Di Napoli, Enrica Mazzoni, Claudia Marchetti, Alice Bergamini, Michele Orditura, Giorgio Valabrega, Giovanni Scambia, Giuseppa MalteseElisabetta De Matteis, Cinzia Cardalesi, Vera Loizzi, Serena Boccia, Emanuele Naglieri, Giuseppa Scandurra, Sandro Pignata

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome. Gynecologic oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences